Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. van Boven (Groningen, Netherlands). Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value?. 3876

Member's Comments

No comment yet.

Related content which might interest you: Is treatment with ICS and LABA good value for money for COPD? Multinational cost-effectiveness analysis of the TORCH study Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002 First steps at implementing value based healthcare internationally in sarcoidosis: comparing outcomes. Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 REG endpoint validation: Do database asthma control measures predict future risk? Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Source: Eur Respir J 2010; 35: 532-539 Year: 2010 Primary asthma prevention amongst children — A cost-effectiveness analysis in a decision-analytic framework Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Evidence-based performance indicators of primary care for asthma: A modified RAND appropriateness method Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Added value of electronic monitoring in the assessment of asthma control? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Development of a decision tree based on real life primary care data: Can we predict the diagnoses asthma, COPD and asthma/COPD overlap syndrome based on automatic data analysis? Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care Year: 2014 Decision analytic models in COPD/asthma: A critical review of current evidence Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Estimating exacerbation rates from routine UK primary care data: an exploratory validation from the IMP2ART programme. Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation Source: Eur Respir J 2014; 43: 554-565 Year: 2013 Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study Source: International Congress 2018 – COPD management Year: 2018 The GOLD COPD categories are inaccurate in predicting future risk in a UK primary care dataset and the 2014 changes to cut-off values have not helped Source: International Congress 2014 – Respiratory disease management in primary care Year: 2014 Assessment of asthma control based on French guidelines criteria. Results from a pharmacy-based study Source: Eur Respir J 2006; 28: Suppl. 50, 684s Year: 2006